NORDEA INVESTMENT MANAGEMENT AB - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 145 filers reported holding ASSERTIO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORDEA INVESTMENT MANAGEMENT AB ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$1,056,000
-62.6%
825,168
+0.7%
0.00%
-66.7%
Q2 2019$2,827,000
-31.7%
819,390
+0.4%
0.01%
-33.3%
Q1 2019$4,140,000
-52.1%
816,231
-65.9%
0.01%
+28.6%
Q4 2018$8,640,000
+5.0%
2,393,706
+71.0%
0.01%
-22.2%
Q3 2018$8,232,0001,399,8980.01%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Senvest Management, LLC 5,006,637$29,439,0002.23%
ARMISTICE CAPITAL, LLC 3,000,000$17,640,0001.06%
DELTEC ASSET MANAGEMENT LLC 517,606$3,044,0000.58%
PERKINS CAPITAL MANAGEMENT INC 125,550$738,0000.44%
Matarin Capital Management, LLC 600,223$3,529,311,0000.23%
GLOBEFLEX CAPITAL L P 196,615$1,156,0000.23%
ALGERT GLOBAL LLC 139,129$818,0000.18%
TSP Capital Management Group, LLC 53,575$315,0000.16%
CORNERCAP INVESTMENT COUNSEL INC 157,235$925,0000.12%
Connor, Clark & Lunn Investment Management Ltd. 3,060,189$17,994,0000.10%
View complete list of ASSERTIO THERAPEUTICS INC shareholders